NCT02609815View on ClinicalTrials.gov

Initial Combination of Gemigliptin and Metformin on Microbiota Change

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 1, 2015

Primary Completion Date

March 15, 2021

Study Completion Date

March 15, 2021

Conditions
Diabetes
Interventions
DRUG

gemigliptin/metformin

zemimet-SR 50/1000 mg x 1 tablet

DRUG

glimepiride/metformin

amaryl-Mex 1/500 mg x 2 tablets

Trial Locations (1)

463-707

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER

NCT02609815 - Initial Combination of Gemigliptin and Metformin on Microbiota Change | Biotech Hunter | Biotech Hunter